Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 10/2018

Ausgabe 10/2018

Inhaltsverzeichnis ( 15 Artikel )

17.08.2018 | Review | Ausgabe 10/2018

Regulatory mechanisms of PD-L1 expression in cancer cells

Yongyu Shi

21.07.2018 | Original Article | Ausgabe 10/2018

Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization

Theresa Barberi, Allison Martin, Rahul Suresh, David J. Barakat, Sarah Harris-Bookman, Charles G. Drake, Michael Lim, Alan D. Friedman

23.07.2018 | Original Article | Ausgabe 10/2018 Open Access

A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

Arjan A. van de Loosdrecht, Sandra van Wetering, Saskia J. A. M. Santegoets, Satwinder Kaur Singh, Corien M. Eeltink, Yvonne den Hartog, Malika Koppes, Jorn Kaspers, Gert J. Ossenkoppele, Ada M. Kruisbeek, Tanja D. de Gruijl

23.07.2018 | Original Article | Ausgabe 10/2018 Open Access

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

Gemma L. Owens, Marcus J. Price, Eleanor J. Cheadle, Robert E. Hawkins, David E. Gilham, Richard J. Edmondson

26.07.2018 | Original Article | Ausgabe 10/2018

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma

Raj K. Kurupati, Xiangyang Zhou, Zhiquan Xiang, Lorraine H. Keller, Hildegund C. J. Ertl

27.07.2018 | Original Article | Ausgabe 10/2018 Open Access

High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with Treg depletion

Mario Löhr, Benjamin Freitag, Antje Technau, Jürgen Krauss, Camelia-Maria Monoranu, Johannes Rachor, Manfred B. Lutz, Carsten Hagemann, Almuth F. Kessler, Thomas Linsenmann, Matthias Wölfl, Ralf-Ingo Ernestus, Sabrina Engelhardt, Götz Gelbrich, Paul G. Schlegel, Matthias Eyrich

28.07.2018 | Original Article | Ausgabe 10/2018

Epidermal growth factor receptor peptide vaccination induces cross-reactive immunity to human EGFR, HER2, and HER3

Hester A. Doyle, Raymond A. Koski, Nathalie Bonafé, Ross A. Bruck, Stephanie M. Tagliatela, Renelle J. Gee, Mark J. Mamula

28.07.2018 | Original Article | Ausgabe 10/2018

Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study

Tony Ibrahim, Christine Mateus, Maria Baz, Caroline Robert

28.07.2018 | Original Article | Ausgabe 10/2018

Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells

Aussara Panya, Chutamas Thepmalee, Nunghathai Sawasdee, Jatuporn Sujjitjoon, Nattaporn Phanthaphol, Mutita Junking, Sopit Wongkham, Pa-thai Yenchitsomanus

31.07.2018 | Original Article | Ausgabe 10/2018

Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice

Álvaro Morales-Molina, Stefano Gambera, Teresa Cejalvo, Rafael Moreno, Miguel Ángel Rodríguez-Milla, Ana Judith Perisé-Barrios, Javier García-Castro

01.08.2018 | Original Article | Ausgabe 10/2018 Open Access

Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine

Hiroaki Shima, Goro Kutomi, Fukino Satomi, Masafumi Imamura, Yasutoshi Kimura, Toru Mizuguchi, Kazue Watanabe, Akari Takahashi, Aiko Murai, Tomohide Tsukahara, Takayuki Kanaseki, Yoshihiko Hirohashi, Yuji Iwayama, Tetsuhiro Tsuruma, Hidekazu Kameshima, Noriyuki Sato, Toshihiko Torigoe, Ichiro Takemasa

01.08.2018 | Original Article | Ausgabe 10/2018

3-Day monocyte-derived dendritic cells stimulated with a combination of OK432, TLR7/8 ligand, and prostaglandin E2 are a promising alternative for cancer immunotherapy

Dag Heiro Yi, Nadine Stetter, Kjerstin Jakobsen, Roland Jonsson, Silke Appel

04.08.2018 | Original Article | Ausgabe 10/2018

Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein

Zeyan Pan, Shengmeng Di, Bizhi Shi, Hua Jiang, Zhimin Shi, Ying Liu, Yi Wang, Hong Luo, Min Yu, Xiuqi Wu, Zonghai Li

18.08.2018 | Original Article | Ausgabe 10/2018

Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism

Ting Chen, Qing Li, Jiao Wu, Yaxin Wu, Wei Peng, Huan Li, Jianmei Wang, Xiaowei Tang, Yan Peng, Xiangsheng Fu

03.08.2018 | Clinical Trial Report | Ausgabe 10/2018

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma

Mark R. Albertini, Richard K. Yang, Erik A. Ranheim, Jacquelyn A. Hank, Cindy L. Zuleger, Sharon Weber, Heather Neuman, Greg Hartig, Tracey Weigel, David Mahvi, Mary Beth Henry, Renae Quale, Thomas McFarland, Jacek Gan, Lakeesha Carmichael, KyungMann Kim, Hans Loibner, Stephen D. Gillies, Paul M. Sondel

Aktuelle Ausgaben


 

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise